Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
The role of genetic variation in VKORC1 and GGCX on warfarin response in a South African population
Background: Warfarin is the most commonly used drug in the management of thromboembolic disease. However, there is a huge variability in the management of warfarin affecting the international normalized ratio (INR). Many genetic-association studies have reported on European and Asian populations whi...
Saved in:
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Thesis |
| Language: | English |
| Published: |
Department of Pathology
2019
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: The role of genetic variation in VKORC1 and GGCX on warfarin response in a South African population
- The role of warfarin pharmacogenomics on the time it takes to reach stable therapeutic International Normalized Ratio (INR) and on warfarin dose required to maintain stable therapeutic INR in Black African and Mixed Ancestry South Africans: a focus on CYP2C9 and VKORC1
- Pharmacogenomics of warfarin: comprehensive evaluation of important warfarin genomic response factors
- The impact of the cytochrome CYP2C9*2 and *3 polymorphisms in the South African Caucasian population on warfarin therapy protocols
- Warfarin time in therapeutic range of primary healthcare patients in the Western Cape, South Africa
- The occurance of genetic variations in the MYH9 gene and their association with CKD in a mixed South African population
- Anatomical study of the variation in the branching patterns and histology of the aorta in a South African population